TSCO
55
-2
DOV
63
-6
NWL
32
-3
TRV
64
-3
ADI
56
-3
AIG
51
-2
ED
53
-5
PG
51
-2
DTE
56
-7
COST
51
-3
BAC
39
-2
CCI
36
-5
MA
65
-4
HSY
38
-2
TGNA
51
3
GD
57
-2
LH
55
2
CMG
50
-6
NEE
52
-2
ICE
64
-5
TSCO
55
-2
DOV
63
-6
NWL
32
-3
TRV
64
-3
ADI
56
-3
AIG
51
-2
ED
53
-5
PG
51
-2
DTE
56
-7
COST
51
-3
BAC
39
-2
CCI
36
-5
MA
65
-4
HSY
38
-2
TGNA
51
3
GD
57
-2
LH
55
2
CMG
50
-6
NEE
52
-2
ICE
64
-5
Financhill
Back

Alimera Sciences Quote, Financials, Valuation and Earnings

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
61

ALIM
Alimera Sciences

Last Price:
5.54
Seasonality Move:
-13.1%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Alimera Sciences Price Quote

$5.54

Alimera Sciences Key Stats

Buy
61
Alimera Sciences (ALIM) is a Buy
Day range:
$5.54 - $5.54
52-week range:
$2.61 - $5.65
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.68
P/B ratio:
7.77%
Volume:
0
Avg. volume:
1.2M
1-year change:
73.67%
Market cap:
$301.3M
Revenue:
$80.8M
EPS:
$-0.31

How Much Does Alimera Sciences Make?

Is Alimera Sciences Growing As A Company?

  • What Is Alimera Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.54%
  • What Is Alimera Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Alimera Sciences Stock Price Performance

  • Did Alimera Sciences Stock Go Up Last Month?
    Alimera Sciences share price went down by -0.72% last month
  • Did ALIM's Share Price Rise Over The Last Year?
    ALIM share price rose by 73.67% over the past 1 year

What Is Alimera Sciences 52-Week High & Low?

Alimera Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Alimera Sciences?

  • How Much Debt Does Alimera Sciences Have?
    Total long term debt quarterly is $69.7M
  • How Much Cash Does Alimera Sciences Have?
    Cash and short term investments quarterly total is $10.8M
  • What Is Alimera Sciences’s Book Value Per Share?
    Book value per share is 0.74

Is Alimera Sciences Cash Flow Positive?

  • What Is ALIM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.6M
  • What Is Alimera Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2M
  • What Is Alimera Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$221K

Alimera Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    ALIM return on invested capital is -13.3%
  • What Is Alimera Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is -9.6%
  • What Is ALIM Return On Equity?
    ROE is a measure of profitability and is -33.3%

Alimera Sciences Earnings Date & Stock Price

Alimera Sciences Competitors

  • Who Are Alimera Sciences's Competitors?
    Below is a list of companies who compete with Alimera Sciences or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Altimmune Inc (ALT)
    • ANI Pharmaceuticals Inc (ANIP)
    • G1 Therapeutics Inc (GTHX)
    • Reneo Pharmaceuticals Inc (RPHM)

Alimera Sciences Dividend Yield

Alimera Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -339.33%
Revenue: 53.95% 4.93%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 5.67
Upside from Last Price: 2.29%

Major Shareholders

  • How many ALIM shares are owned by institutional investors?
    50.3M ALIM shares are owned by institutional investors
  • How many ALIM shares are owned by insiders?
    1.6M ALIM shares are owned by insiders